Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1497 - 1504 of 11454 results
Artificial Intelligence (AI) Takes a Role in USPTO Patent Searches
November 8, 2022| Blog| Viewpoint
No Election Day Holiday This Year. Big Law Employees Have A Few Hours For Voting
November 8, 2022| News
Some Employers Still Require COVID-19 Vaccines
November 8, 2022| News
Form I-9 Requirements Flexibility Extended Until July 31, 2023
November 7, 2022| Blog| Viewpoint
Accounting Standard-Setter To Require Scope 3 Disclosure
November 7, 2022| News
"Journeys From There to Here” with Susan Cohen
November 5, 2022| News
NYC Proposes Rules in Advance of 2023 Automated Employment Decision Tools Law
November 4, 2022| Blog| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.